| Diet and peripheral arterial occlusive disease: the role of poly-, mono-, and saturated fatty acids. | |
| | |
MedLine Citation:
|
PMID: 1983895 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A case-control study concerning the association between diet and peripheral arterial occlusive disease was conducted in Athens, Greece. The case series consisted of 100 patients with this disease, whereas controls were 100 patients with conditions requiring minor surgical care who were admitted to the same teaching hospital. Diet was ascertained through a semiquantitative food frequency questionnaire. Nutrient intakes for individuals were estimated by multiplying the nutrient content of a selected typical portion size for each specified food item by the frequency that the food was used per month and summing these estimates for all food items. Data were analyzed using multiple logistic regression procedures, controlling for total energy intake by taking nutrient residuals and by using multivariate nutrient density models. Saturated fatty acids (odds ratio (OR) and 95% confidence interval (CI) contrasting the 75th centile (upper) with the 25th centile = 1.96 and 1.14-3.39), proteins (OR = 2.86, 95% CI 1.47-5.55), and dietary cholesterol (OR = 6.07, 95% CI 2.74-13.46) were associated with increased risk of peripheral arterial occlusive disease, whereas polyunsaturated fatty acids (OR = 0.48, 95% CI 0.24-0.93) and crude fiber (OR = 0.33, 95% CI 0.17-0.64) were related to reduced risk. Monounsaturated fatty acids and, by inference, olive oil occupy an intermediate neutral position between polyunsaturates and saturates (corresponding OR = 1.14, 95% CI 0.68-1.91). Higher intakes of fiber and vitamin C were associated with lower risk of peripheral arterial occlusive disease. The low occurrence of atherosclerotic diseases in Greece and other Mediterranean countries may be due to the substitution of olive oil in place of saturated fats and/or the consumption of a diet high in vegetables, fruits, and other fiber-containing foods. |
| | |
Authors:
|
K Katsouyanni; Y Skalkidis; E Petridou; A Polychronopoulou-Trichopoulou; W Willett; D Trichopoulos |
Related Documents
:
|
11688435 - A framework for food-based dietary guidelines in the european union. 12664525 - Update on technical issues concerning complementary feeding of young children in develo... 3655165 - Food, supplements, and fortified foods: scientific evaluations in regard to toxicology ... 9155815 - Effects of orthodontic treatment on nutrient intake. 17916885 - Smooth handling: the lack of safety-related consumer information in car advertisements. 19490325 - Purification and use of glycomacropeptide for nutritional management of phenylketonuria. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: American journal of epidemiology Volume: 133 ISSN: 0002-9262 ISO Abbreviation: Am. J. Epidemiol. Publication Date: 1991 Jan |
Date Detail:
|
Created Date: 1991-01-17 Completed Date: 1991-01-17 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 7910653 Medline TA: Am J Epidemiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 24-31 Citation Subset: IM |
Affiliation:
|
Department of Hygiene and Epidemiology, University of Athens Medical School, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arterial Occlusive Diseases
/
epidemiology* Case-Control Studies Diet Surveys Eating* Fatty Acids / metabolism* Fatty Acids, Monounsaturated / metabolism* Fatty Acids, Unsaturated / metabolism* Humans Nutritional Physiological Phenomena* Odds Ratio Regression Analysis Risk Factors Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Fatty Acids; 0/Fatty Acids, Monounsaturated; 0/Fatty Acids, Unsaturated |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessment of the prevalence and risk factors for human immunodeficiency virus type 1 (HIV-1) infect...
Next Document: Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease.